Research Solutions FY26: Record Net Income but ARR Growth Decelerates

What happened

Research Solutions reported fiscal year 2026 results with record net income of $2.8 million, but B2B ARR growth slowed to 14% year-over-year, with total ARR reaching $22.5 million. This compares to 21% total ARR growth in Q1 FY26 and management's earlier emphasis on 'strongest organic Q1 B2B ARR growth ever,' indicating a meaningful deceleration. The master report had highlighted ARR growth of ~20%+ as a key condition for a stronger investment stance, and this slower pace may undermine that thesis. However, the shift to sustained GAAP profitability and positive free cash flow, as noted in the master report, continues to support balance sheet strength, with the company remaining net cash. The narrow moat and competitive risks, including supplier concentration and open access threats, remain unchanged, and the press release's 'leading AI-powered research workflow platform' claim should be treated with skepticism given the competitive landscape.

Implication

The reported ARR growth of 14% falls short of the master report's threshold of ~20%+ that would have supported a more constructive stance, suggesting the growth pillar is weakening. While record net income of $2.8 million is a positive step, it remains modest relative to the company's market capitalization and may not justify a premium valuation. The narrow moat and structural risks from open access and direct publisher platforms continue to threaten the transactional business, while Platforms growth may not be sufficient to offset. Investors should monitor whether the slowdown is temporary due to seasonality or a sign of market saturation, and whether Platforms mix and gross margins continue to improve. Until clearer evidence of re-acceleration or a durable margin expansion emerges, a cautious approach is warranted, and the previous POTENTIAL BUY stance should likely be downgraded to WAIT or POTENTIAL SELL until further data.

Thesis delta

The thesis previously leaned on ARR growth of ~20%+ and improving margins to justify potential upside. The reported 14% B2B ARR growth indicates a deceleration that undermines the growth assumption, though record net income shows improved profitability. As a result, the investment thesis shifts from asymmetric upside to a more cautious watch, with particular attention to whether ARR growth can re-accelerate or if margins can offset slower revenue growth.